We are seeking a software engineer to support the development of world-class solutions to support our research & translational efforts in NIBR Oncology. Your work would directly accelerate research which brings new, life-saving products to the clinic. Prior experience developing scientific applications in a pharmaceutical or biotech environment is a plus.  [More]

Originally posted on 2017-10-30
2017-10-29  -  Sr. Principal Analyst  -    -  

NIBR Informatics is looking for a degree-educated Senior Principal Analyst Scientific Information Systems with an understanding of biology, research data, and lab workflows, as well as excellent experience in software engineering and informatics, to join a multi-disciplinary Discovery Biology Informatics Group. Work location will be in Cambridge, MA. [More]

Originally posted on 2017-10-30
2017-10-29  -  Computational Biology Lead  -    -  

Lead the cardiovascular and metabolic disease area (CVM-DA) computational biology team. You will be responsible for driving shared global and local strategies to advance the understanding of CVM disease biology to enable target identification, drug development, and patient identification and stratification.  [More]

Originally posted on 2017-10-29
2017-10-29  -  Computational Biologist  -    -  

The Biologics Center (NBC) at the Novartis Institute for BioMedical Research (NIBR) is looking for a motivated and highly experienced computational biologist to join the NBC Informatics group. The Candidate: will have the opportunity to contribute to the discovery and improvement of therapeutic antibodies and proteins... [More]

Originally posted on 2017-10-29

The successful candidate will serve as a biomarker liaison with clinical teams in Translational Clinical Oncology and Oncology Global Development, including the following responsibilities. We are seeking a bioinformatics investigator to accelerate the development of immuno-oncology therapies. Collaborate with Precision Medicine Directors on the design and execution of biomarker profiling studies in clinical trials... [More]

Originally posted on 2017-10-14